THE PHARMACOGENETIC MECHANISMS OF DEVELOPMENT OF METABOLIC DISORDERS ASSOCIATED WITH THE SECOND-GENERATION ANTIPSYCHOTICS
Antipsychotics are the main medication for schizophrenia treatment. Recently the wideused group of them became second-generation antipsychotics (SGA). Due to that, problem of metabolic disturbances as side effect of SGA is more actually. The development of pha…